Table II.
Logistic regression analysis for predicting hyperinsulinemia.
| Models | B | SE | P-value | OR (95% CI) |
|---|---|---|---|---|
| Model I | ||||
| −Decrease in CD19+CD24hiCD38hi/CD19+ | 0.043 | 0.022 | 0.041 | 1.044 (1.0011.090) |
| −Decrease in CD19+CD24hiCD38hi/L | 0.338 | 0.122 | 0.006 | 1.402 (1.103–1.782) |
| Model II | ||||
| −Decrease in CD19+CD24hiCD38hi/CD19+ | 0.05 | 0.024 | 0.038 | 1.051 (1.003–1.102) |
| −Decrease in CD19+CD24hiCD38hi/L | 0.365 | 0.148 | 0.014 | 1.440 (1.076–1.926) |
| Model III | ||||
| −Decrease in CD19+CD24hiCD38hi/L | 0.046 | 0.024 | 0.035 | 1.372 (1.022–1.843) |
Model I, variables were introduced into the logistic regression model; Model II, adjustment for confounding factors including anti-thyroid peroxidase antibodies, anti-thyroglobulin antibodies, age and gender; Model III, further adjustment for height, weight, body mass index, waist and hip circumferences, and blood pressure. B, regression coefficient; SE, standard error; OR, odds ratio; CI, confidence interval; L, lymphocytes.